“PRISM microscope” promises rapid, real-time diagnostics including for Covid-19.

Funded by US directed energy weapons development agency, the Joint Directed Energy Transition Office.

Developments from Schott, tec5 and CEA-Leti offer improved process control and imaging.

Massachusetts firm is taking laser-based treatment of rare and often incurable ocular cancer to pivotal trial.

Founder Andrew Rickman remains as CEO and Chairman, as diversified silicon photonics player is set to trade on NYSE as “RKLY”.

Industrial materials processing specialist expands group’s sheet metal treatment capabilities.

Laser company is evaluating Lumentum's latest offer, with deadline of March 24 set.

Wellman Center imaging technique could help identify arterial plaques most likely to rupture.

Quantifying subsurface bubbles key to oceanographic models to characterize sea evolution.

Detection limit two orders of magnitude better than equivalent-size piezoelectric; aimed at medical photoacoustic imaging.

Lumentum given until March 22 to respond as II-VI’s latest cash-plus-stock offer is deemed ‘superior’.

Latest bid now includes $1 billion in support from investor Silver Lake.